IFP Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.9K | Sell |
5,705
-10,103
| -64% | -$51.1K | ﹤0.01% | 2345 |
|
|
2025
Q1 | $83.6K | Buy |
15,808
+3,977
| +34% | +$21K | ﹤0.01% | 1625 |
|
|
2024
Q4 | $80K | Buy |
11,831
+7,455
| +170% | +$50.4K | ﹤0.01% | 1583 |
|
|
2024
Q3 | $28.8K | Buy |
4,376
+2,875
| +192% | +$18.9K | ﹤0.01% | 1987 |
|
|
2024
Q2 | $11.3K | Buy |
1,501
+500
| +50% | +$3.75K | ﹤0.01% | 2303 |
|
|
2024
Q1 | $9.98K | Buy |
1,001
+1,000
| +100,000% | +$9.97K | ﹤0.01% | 2234 |
|
|
2023
Q4 | $10 | Hold |
1
| – | – | ﹤0.01% | 3021 |
|
|
2023
Q3 | $8 | Buy |
+1
| New | +$8 | ﹤0.01% | 3274 |
|